Investor Relations

Corporate Governance - Highlights

Dr. Stanley Hirsch
Chairman and Member of the Compensation Committee
Dr. Stanley Hirsch
Chairman and Member of the Compensation Committee


Stanley Hirsch, D.Phil., has served as our director since February 2005. Dr. Hirsch has 28 years of experience in executive positions, including director of business development for a privately held group of healthcare companies. He has also served as general manager of two diagnostics development companies. Dr. Hirsch has been CEO at FuturaGene Ltd., and its predecessor company CBD Technologies Ltd., since 1989, and has also held the position of General Manager of Portman Pharmaceutical Industr... 
Stanley Stern
Member of the Audit Committee and Compensation Committee
Stanley Stern
Member of the Audit Committee and Compensation Committee


Mr. Stanley Stern has 30 years of experience as an investment banker, working for Salomon Brothers, Oppenheimer & Co, STI Ventures and C.E. Unterberg. In 2013, Mr. Stern founded Alnitak Capital Partners which provides strategic advice and conducts merchant banking activities. Mr. Stern holds a B.A. in Economics andAccounting from City University of New York, Queen College, and an M.B.A. from Harvard University.... 
Rex Bright
Chairman of the Compensation Committee and Member of the Audit Committee
Rex Bright
Chairman of the Compensation Committee and Member of the Audit Committee


Mr. Rex Bright has held CEO positions in the health care industry for the past 20 years. Mr. Bright was the co-founder and CEO of SkinMedica, a specialty pharmaceutical business that was later acquired by Allergan. Mr. Bright has worked in executive positions for Johnson & Johnson and GlaxoSmithKline. Mr. Bright holds a B.A. in Business Administration and Marketing from Drury College, Missouri.... 
Dr. Aaron Schwartz
Dr. Aaron Schwartz

Dr. Aaron Schwartz served in a number of positions at Teva from 1975 through 2011. After serving 7 years as the head of the pharmaceutical division of Teva in Israel, Dr. Schwartz created the Copaxone division of Teva in 1992 and led it for 9 years. His most recent position was Vice President, Head of Teva Innovative Ventures - TIV, which he held from 2008 to 2011.
Dr. Schwartz is currently chairman of the board for several life science companies. Dr. Schwartz received a Ph.D. in organ... 

Dr. Darrell Rigel
Member of the Audit Committee and Compensation Committee
Dr. Darrell Rigel
Member of the Audit Committee and Compensation Committee


Dr. Darrell Rigel is a Clinical Professor of Dermatology at the New York University Medical School, anAdjunct Clinical Professor of Dermatology at the Mount Sinai School of Medicine, as well as being an Attending at the Tisch and Bellevue Hospitals in New York. Dr. Rigel holds an SB in Management Information Sciences and an SM in Management Information Science from the Massachusetts Institute of Technology and an M.D. from the George Washington University School of Medicine.... 
Dr. Dov Tamarkin
Dr. Dov Tamarkin

Dr. Tamarkin is a co-founder of the Company and co-inventor of the Foamix Foam and OilGel technologies. He has more than twenty five years experience in the direction of preclinical, clinical and regulatory phases of drug development. He has held positions of senior R&D section manager at Teva Pharmaceuticals and served as VP of R&D at Portman Pharmaceuticals, a company that develops immunologic therapies for Type I diabetes and other autoimmune diseases.

Dr. Tamarkin has extensive ... 

Dr. Anna  Kazanchyan
Dr. Anna  Kazanchyan

Dr. Kazanchyan is a biotechnology executive with a unique combination of clinical, equity research, business strategy and business development expertise. She has 15+ years of experience at marquee Wall Street firms, biopharmaceutical companies and as an entrepreneur. Dr. Kazanchyan is the founder and Managing Partner of Primary i-Research, LLC, where she provides due diligence to leading healthcare investment funds and evaluates investment prospects of biopharmaceutical companies based on the sc... 
Dr. Dalia Megiddo
Dr. Dalia Megiddo

Dr. Dalia Megiddo is an experienced healthcare and investment professional in the pharmaceutical and healthcare sectors. She has co-founded a number of pharma companies, including Alcobra Ltd. (Nasdaq: ADHD), Bioblast-Pharma Ltd. (Nasdaq: ORPN) and Chiasma Ltd. (Nasdaq: CHMA). She currently serves as Managing Partner of Expedio Ventures, and previously ran other life science investment funds, including Jerusalem Global Ventures and 7-Health.

Dr. Megiddo serves as a director of Biobla... 

Dr. Dov  Tamarkin
CEO
Dr. Dov  Tamarkin
CEO


Dr. Tamarkin is a co-founder of the Company and co-inventor of the Foamix Foam and OilGel technologies. He has more than twenty five years experience in the direction of preclinical, clinical and regulatory phases of drug development. He has held positions of senior R&D section manager at Teva Pharmaceuticals and served as VP of R&D at Portman Pharmaceuticals, a company that develops immunologic therapies for Type I diabetes and other autoimmune diseases.

Dr. Tamarkin has extensive ... 

Meir Eini
Chief Innovation Officer
Meir Eini
Chief Innovation Officer


Mr. Eini is a co-founder of the Company and co-inventor of the Foamix Oil Gel and Foam technologies. He has 25 years of experience in healthcare and marketing and is an experienced entrepreneur. Between 2000 and 2003, Mr. Eini founded and served as the Chief Executive Officer of Flexiprobe Ltd., the developer of a medical device for women’s health. Prior to that, Mr. Eini was the Founder and President of Clilco Ltd., a company engaged in the development and commercialization of non-prescription ... 
David Domzalski
President
David Domzalski
President


David Domzalski serves as the President of our U.S. subsidiary, Foamix Pharmaceuticals Inc., and has been with us since April 2014. Mr. Domzalski has 20 years of industrial experience, previously holding positions as Vice President Sales and Marketing at LEO Pharma Inc. from 2009 to July 2013, Senior Vice President and General Manager at Azur Pharma from 2008 to 2009, and Vice President Sales and Marketing at Warner Chilcott from 2003 to 2008. Mr. Domzalski holds a B.A. in economics and politica... 
Ilan Hadar
CFO
Ilan Hadar
CFO


Ilan Hadar has served as our Chief Financial Officer since February 2014. Mr. Hadar has 18 years of experience in executive financial positions, previously holding positions as Finance Director of the Israeli subsidiary of Pfizer from 2011 to 2013, as Finance Manager,Accounting and Reporting at the Israeli subsidiary of HP from 2007 to 2011, and prior to that as Finance Director of the Israeli subsidiary of BAE Systems. Mr. Hadar holds a B.A. in business administration and economics and an MBA f... 
David Schuz
Executive Vice President, Intellectual Property
David Schuz
Executive Vice President, Intellectual Property


David Schuz has served as our Executive Vice President since 2010 and as our Senior Vice President, for intellectual property since July 2006. Mr. Schuz has 20 years of experience in the field of intellectual property in relation to the pharmaceuticals and biotechnology industries, previously holding various intellectual property and legal positions at Biotechnology General Israel Ltd. and Savient Pharmaceuticals, Inc. between 1996 and 2006, including Vice President from 2003. Mr. Schuz holds an... 
Dr. Mitchell  Shirvan
Sr. Vice President, Innovative R&D
Dr. Mitchell  Shirvan
Sr. Vice President, Innovative R&D


Mitchell Shirvan, Ph.D., has served as our Senior Vice President of Research and Development since March 2014. Dr. Shirvan has over 20 years of experience in the pharmaceuticals and biotechnology industry, previously holding positions of Chief Executive Officer at Macrocure Ltd. from 2008 to 2012 and as Senior Director, Strategic Business Planning and Senior Manager, Research and Development at Teva Pharmaceutical Industries between 1992 and 2008. Dr. Shirvan holds a Ph.D. in microbiology from T... 
Dr. Herman  Ellman
Vice President, Clinical Development
Dr. Herman  Ellman
Vice President, Clinical Development


Herman Ellman, M.D., has served as our Vice President of Clinical Development since April 2014. Dr. Ellman has over 25 years of experience in the pharmaceutical industry, previously holding positions as Senior Vice President for Clinical Development at Warner Chilcott from 2000 to 2013 and Medical Director at Berlex Laboratories from 1995 to 2000. Dr. Ellman holds a M.D. from the State University of New York, Downstate Medical Center and Boards in Internal Medicine, Pulmonary Diseases and Critic... 
Alvin Howard
Vice President, Regulatory Affairs
Alvin Howard
Vice President, Regulatory Affairs


Alvin Howard has served as our Vice President of Regulatory Affairs since April 2014. Mr. Howard has over 30 years of industry experience, previously holding positions as Senior Vice President of Regulatory Affairs in Warner Chilcott from 2005 to 2013, Vice President of Regulatory Affairs at Roberts Pharmaceuticals from 1998 to 2000 and various positions at Solvay Pharmaceuticals from 1990 to 1998. Mr. Howard holds a B.Sc. in chemistry from Stillman College, Tuscaloosa, Alabama.... 
Yohan Hazot
CTO
Yohan Hazot
CTO


Yohan Hazot has served as our Chief Technology Officer since December 2014. Mr Hazot has been with us since April 2007 in several positions in the field of drug development and intellectual property, and lately held the position of Director of Pharmaceutical Development. Mr Hazot holds an MSc in Biochemistry & Biotechnology from the National Institute of Applied Sciences, Lyon, France and is the inventor of several patents in the field of pharmaceutical chemistry.... 
Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit Committee Compensation Committee
Rex Bright 
Rex Bright
Chairman of the Compensation Committee and Member of the Audit Committee


Mr. Rex Bright has held CEO positions in the health care industry for the past 20 years. Mr. Bright was the co-founder and CEO of SkinMedica, a specialty pharmaceutical business that was later acquired by Allergan. Mr. Bright has worked in executive positions for Johnson & Johnson and GlaxoSmithKline. Mr. Bright holds a B.A. in Business Administration and Marketing from Drury College, Missouri.... 
Committee Member Chairperson
Dr. Stanley Hirsch 
Dr. Stanley Hirsch
Chairman and Member of the Compensation Committee


Stanley Hirsch, D.Phil., has served as our director since February 2005. Dr. Hirsch has 28 years of experience in executive positions, including director of business development for a privately held group of healthcare companies. He has also served as general manager of two diagnostics development companies. Dr. Hirsch has been CEO at FuturaGene Ltd., and its predecessor company CBD Technologies Ltd., since 1989, and has also held the position of General Manager of Portman Pharmaceutical Industr... 
  Chairperson
Dr. Anna  Kazanchyan 
Dr. Anna  Kazanchyan

Dr. Kazanchyan is a biotechnology executive with a unique combination of clinical, equity research, business strategy and business development expertise. She has 15+ years of experience at marquee Wall Street firms, biopharmaceutical companies and as an entrepreneur. Dr. Kazanchyan is the founder and Managing Partner of Primary i-Research, LLC, where she provides due diligence to leading healthcare investment funds and evaluates investment prospects of biopharmaceutical companies based on the sc... 
  Committee Member
Dr. Darrell Rigel 
Dr. Darrell Rigel
Member of the Audit Committee and Compensation Committee


Dr. Darrell Rigel is a Clinical Professor of Dermatology at the New York University Medical School, anAdjunct Clinical Professor of Dermatology at the Mount Sinai School of Medicine, as well as being an Attending at the Tisch and Bellevue Hospitals in New York. Dr. Rigel holds an SB in Management Information Sciences and an SM in Management Information Science from the Massachusetts Institute of Technology and an M.D. from the George Washington University School of Medicine.... 
Committee Member Committee Member
Stanley Stern 
Stanley Stern
Member of the Audit Committee and Compensation Committee


Mr. Stanley Stern has 30 years of experience as an investment banker, working for Salomon Brothers, Oppenheimer & Co, STI Ventures and C.E. Unterberg. In 2013, Mr. Stern founded Alnitak Capital Partners which provides strategic advice and conducts merchant banking activities. Mr. Stern holds a B.A. in Economics andAccounting from City University of New York, Queen College, and an M.B.A. from Harvard University.... 
Chairperson Committee Member